Exelixis Diacheirisi Erevnas Kai Epikoinonia Ee

Exelixis Diacheirisi Erevnas Kai Epikoinonia Ee is an SME in Gerakas Attiki, Greece that has taken part in 10 EU-funded projects since 2017, receiving €1.5M in EU funding.

EU funding received€1.5M
EU projects10
As coordinator0
Running now4
First EU project2017
Latest project2026
CountryGreece
EU registration (PIC)949673748
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Exelixis Diacheirisi Erevnas Kai Epikoinonia Ee's own share of each project, not the project's full budget.

  • Horizon 2020€805k · 5 projects
  • Horizon Europe€710k · 5 projects

Projects

10 EU-funded projects, newest first. Each links to the official record.

  • DiagMDSAssociated partner

    Towards novel approaches for Myelodysplastic Syndromes diagnosis to Strengthen Research Human Capital with Cross-Sectoral and Interdisciplinary Staff mobility

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • EXPAND-EVAssociated partner

    EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision healthcare

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • MULTIRPartner

    MULti-Tumour based prediction and manipulation of Immune Response

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €278ktheir share
  • ELMUMYPartner

    Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €263ktheir share
  • L2D2Partner

    Laser digital transfer of 2D materials enabled photonics: from the lab 2 the fab

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €170ktheir share
  • TO_AITIONPartner

    A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €250ktheir share
  • SENSITIVEPartner

    Early Detection of cancer onset based on sensing field cancerization at the organ level

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €135ktheir share
  • LEAF-2DPartner

    Laser EnAbled TransFer of 2D Materials

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €116ktheir share
  • CUREPartner

    Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €123ktheir share
  • HarmonicSSPartner

    HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €183ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • additive manufacturing
  • allergology
  • asthma
  • big data
  • bladder cancer
  • cell biology
  • data mining
  • drug discovery
  • graphene
  • hematology
  • immunology
  • laser physics
  • lung cancer

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime